Waiting for test results can be a minor inconvenience for some patients, but for those who are critically ill, timing matters. At the CPOCT International Symposium in Copenhagen (21-24 September) Dr Craig Lilly, a professor of medicine at the University of Massachusetts spoke about the point-of-care testing market, outlining currently available testing for critically ill adults, and also under…
An international study, led by the University of Southampton, shows the UK and France experience the highest number of malaria cases imported from other countries.
The reprocessing of medical devices in Europe is very inconsistent, according to a European Commission survey that was carried out in the 27 EU member states among politicians, medical device manufacturers and reprocessing companies, as well as doctors, hospitals and related professional parties
A global spotlight has at last highlighted the truly acute problem of antimicrobial resistance.
European regulators have turned the world of in vitro diagnostics (IVDs) upside down with new legislation that will come into effect at the end of this year. The new EU legislation gives manufacturers five years to meet strict standards. That may not be enough time.
The increasing numbers of bacteria resistant to the newer generations of antibiotics is a public health problem on a global scale. Bacteria have an extraordinary capacity for adaptation, mutating permanently to overcome the action of our increasingly impotent antimicrobial armamentarium. A situation further aggravated by the use of the powerful ‘large spectrum’ antibiotics, creating further…
Our knowledge of causes and mechanisms of current and future diseases is on ice – not the perpetual ice of the polar caps but artificial ice. It is stored in biobanks at -80 to -160 °C.
From barcode scanning, RFID and medical machine vision to chart recorders, thermal printers and spectroscopy products, JADAK designs and manufactures embedded solutions that help customers solve unique inspection, tracking, scanning and documenting challenges.
‘BioLogical’ is the name of the new customer magazine by Greiner Bio-One. It will be published biannually and provide you with the latest findings on current topics and information about relevant innovative product developments – content designed specifically to appeal to medical, laboratory researcher or academic professionals.
In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.
When one cell divides into two - that is how all forms of life are propagated - the newly born daughter cells have to be equipped with everything they will need in their tiny lives. Most important of all is that they inherit a complete copy of the genetic information from their mother cell. If this is not the case because a wrong number of chromosomes – on which the genetic information is…
The newest addition to the RX series, the RX modena, is a high volume, fully automated clinical chemistry analyser that promises to revolutionise your laboratory and transform diagnostics.
For the first time, scientists know what happens to a virus’ shape when it invades a host cell, thanks to an experiment by researchers at Penn State College of Medicine and University of Pittsburgh School of Medicine. Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
‘Lab medicine connects’ is the congress theme of the German Congress of Laboratory Medicine and reflects the fact that laboratory medicine is an interdisciplinary subject like no other and connects those who are involved in medicine across disciplines. It works almost imperceptibly in the background, hardly noticed by patients. European Hospital spoke with this year’s Congress President,…
A mobile fridge invented by a British student could help save countless lives across the globe. The “Isobar” has been designed to keep vaccines at the required temperatures when being transported around developing countries.
To treat or not to treat? That is the question researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) hope to answer with a new advance that could help doctors and their cancer patients decide if a particular therapy would be worth pursuing.
Curetis announced the signing of an asset acquisition agreement with the Siemens Technology Accelerator GmbH (STA). Under the terms of the agreement, Curetis has acquired sole commercial rights from STA to the GEAR GEnetic Antibiotic Resistance and Susceptibility platform and database with all its content, numerous GEAR-related patents and patent applications, as well as all corresponding…
Nowadays, the variety of clinical laboratories in a hospital setting is endless, especially due to the constant advent of new technology and scientific discovery.
Siemens Healthineers announced today it released a major software upgrade for the RAPIDComm Data Management System (V6.0), an informatics solution to centrally manage in vitro diagnostics analyzers and operators at the point-of-care (POC). In addition to the system’s enhanced productivity and performance features, RAPIDComm V6.0 now connects with POC cardiac devices.
Siemens Healthineers unveiled the Atellica Solution(1), a highly flexible immunoassay and clinical chemistry solution featuring patented bi-directional magnetic sample-transport technology that is 10 times faster than conventional conveyors.(1)The unveiling occurred during the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia.
IBM scientists have developed a new lab-on-a-chip technology that can, for the first time, separate biological particles at the nanoscale and could enable physicians to detect diseases such as cancer before symptoms appear.
Our mission at the Sysmex Corporation is defined very clearly in our corporate policy: in all that we do, our focus must be on Shaping the Advancement of Healthcare. Of course, there are a million mission statements out there, with all underlying companies claiming that they will change the world in which they operate. Words can come cheap. But not at Sysmex. By the simple fact that we are the…
Authors Guiseppe Lippi, Chiara Bovo and Emmanuel J. Favaloro offer a glimpse into a new generation of hematology analyzers and discuss the concepts of redesigning coagulation analyzers to fit the most important aspects of the preanalytical, analytical and postanalytical phases in hemostasis testing. The aim of this opinion article is to provide some personal ideas, based on experience and…
Cancer patients today can benefit from much better drugs providing treatments tailor-made to specific mutations. However, broad application is still hampered by a considerable bottleneck: fast, reliable, and cost-effective diagnosis. Agena's MassARRAY platform is addressing this bottleneck with an elegant new solution.
Since several years, LC-MS/MS technology is making an important breakthrough in the field of clinical research. The progress of tandem MS or MS/MS in that field is mainly due to its ability for high sensitivity detection, high selectivity, as well as possibilities of multiplexing compounds in one analysis without the risk of cross reactions inherent to immuno-assay tests.
